New study aims to crack the code on Hard-to-Treat sleep apnea in heart failure
NCT ID NCT07210606
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at why people with heart failure or those taking opioid painkillers develop central sleep apnea (pauses in breathing during sleep). Current treatments don't work well, so researchers will test combinations of breathing machines and medications in 200 Veterans. The goal is to understand the root causes and guide future therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABLE BODIED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
John D. Dingell VA Medical Center, Detroit, MI
Detroit, Michigan, 48201-1916, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could continuing a common heart drug before surgery save lives?
- Could a natural chemical be the key to safer heart failure treatment?
- Can a Breathing-Synchronized pacemaker boost heart function after bypass?
- Can 3D heart scans outperform standard ultrasound in predicting risk?
- Mind over paralysis: can thinking about walking reboot the brain?
- Iron infusions put to the test for heart failure stamina